Citigroup’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-100
| Closed | -$5K | – | 7546 |
|
|
2020
Q3 | $5K | Sell |
100
-500
| -83% | -$23.7K | ﹤0.01% | 7032 |
|
|
2020
Q2 | $23K | Sell |
600
-3,400
| -85% | -$109K | ﹤0.01% | 6514 |
|
|
2020
Q1 | $87K | Buy |
4,000
+3,800
| +1,900% | +$114K | ﹤0.01% | 5462 |
|
|
2019
Q4 | $8K | Sell |
200
-1,500
| -88% | -$61.2K | ﹤0.01% | 7271 |
|
|
2019
Q3 | $72K | Buy |
1,700
+1,500
| +750% | +$62.9K | ﹤0.01% | 5890 |
|
|
2019
Q2 | $10K | Sell |
200
-1,600
| -89% | -$81.4K | ﹤0.01% | 7305 |
|
|
2019
Q1 | $86K | Buy |
1,800
+1,200
| +200% | +$72.7K | ﹤0.01% | 5892 |
|
|
2018
Q4 | $37K | Sell |
600
-1,200
| -67% | -$80.9K | ﹤0.01% | 6476 |
|
|
2018
Q3 | $148K | Buy |
1,800
+600
| +50% | +$47.7K | ﹤0.01% | 5533 |
|
|
2018
Q2 | $94K | Buy |
1,200
+200
| +20% | +$15.5K | ﹤0.01% | 5782 |
|
|
2018
Q1 | $74K | Sell |
1,000
-5,400
| -84% | -$383K | ﹤0.01% | 5875 |
|
|
2017
Q4 | $437K | Buy |
6,400
+800
| +14% | +$51.7K | ﹤0.01% | 4239 |
|
|
2017
Q3 | $344K | Sell |
5,600
-3,800
| -40% | -$233K | ﹤0.01% | 4495 |
|
|
2017
Q2 | $591K | Buy |
9,400
+4,300
| +84% | +$245K | ﹤0.01% | 3835 |
|
|
2017
Q1 | $283K | Buy |
5,100
+500
| +11% | +$25.7K | ﹤0.01% | 4360 |
|
|
2016
Q4 | $220K | Buy |
4,600
+2,500
| +119% | +$140K | ﹤0.01% | 5202 |
|
|
2016
Q3 | $136K | Buy |
2,100
+1,700
| +425% | +$95.6K | ﹤0.01% | 4980 |
|
|
2016
Q2 | $18K | Sell |
400
-400
| -50% | -$16.1K | ﹤0.01% | 6223 |
|
|
2016
Q1 | $31K | Sell |
800
-4,600
| -85% | -$152K | ﹤0.01% | 6343 |
|
|
2015
Q4 | $205K | Sell |
5,400
-2,100
| -28% | -$77.4K | ﹤0.01% | 4723 |
|
|
2015
Q3 | $310K | Sell |
7,500
-3,900
| -34% | -$167K | ﹤0.01% | 4166 |
|
|
2015
Q2 | $537K | Buy |
11,400
+4,100
| +56% | +$222K | ﹤0.01% | 3633 |
|
|
2015
Q1 | $440K | Buy |
7,300
+1,800
| +33% | +$91.6K | ﹤0.01% | 3866 |
|
|
2014
Q4 | $240K | Sell |
5,500
-24,500
| -82% | -$1.08M | ﹤0.01% | 4533 |
|
|
2014
Q3 | $1.35M | Buy |
+30,000
| New | +$1.6M | ﹤0.01% | 2827 |
|
|
2014
Q2 | – | Sell |
-30,000
| Closed | -$2.49M | – | 7249 |
|
|
2014
Q1 | $2.49M | Buy |
+30,000
| New | +$2.64M | ﹤0.01% | 2213 |
|
|
2013
Q4 | – | Sell |
-242,500
| Closed | -$23.2M | – | 7096 |
|
|
2013
Q3 | $23.2M | Buy |
+242,500
| New | +$20.6M | 0.02% | 667 |
|
Other funds holding NUS
VCM
PGCM
VPM
Citigroup's NUS Position: Q1 2026 in Review
Citigroup increased its Nu Skin (NUS) stake by 66% in Q1 2026, buying an estimated $8.04K and bringing the position to 2,240 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4887.
Citigroup first reported a position in NUS in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.58M in Q4 2016. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.
- Citigroup held 2,240 shares of Nu Skin worth $16.3K as of Q1 2026.
- Citigroup bought 888 Nu Skin shares in Q1 2026, an estimated $8.04K.
- Nu Skin made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4887 holding.
- Citigroup first reported a position in Nu Skin in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Nu Skin position peaked at $5.58M in Q4 2016.
- 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.